Boosting Cancer Chemotherapy through Targeted Akkermansia muciniphila Modulation by Tumor-Repopulating Cell-Derived Microparticles
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.5c04399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Shiyu Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 4…. Hauptthemen laut MEDLINE: Doxorubicin, Gastrointestinal Microbiome, Akkermansia, Cell-Derived Microparticles. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The complex relationship between gut microbiota and cancer therapy has received extensive attention, proposing gut microbiota modulation as a promising strategy for enhancing anticancer efficacy. In this work, tumor-repopulating cell-derived microparticles (3D-MPs) encapsulated with doxorubicin (DOX) are developed to improve cancer treatment outcomes through targeted interaction with gut microbiota, particularly Akkermansia muciniphila (AKK). This delivery system efficiently accumulates in the intestines via the integrin α5-fibronectin pathway, promoting AKK abundance through the pro-proliferative effects of 3D-MPs on AKK and the inhibitory action of DOX on competing gut bacteria, such as Helicobacter and Prevotella, for improved anticancer effects. Our findings demonstrate the potential of leveraging gut microbiota modulation to optimize therapeutic outcomes in cancer treatments, offering a novel approach to synergistic cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
- Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
- Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan 430074, China.
ORCID-Profile: Tuying Yong, Lu Gan
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- National Key Research and Development Program of China
Zitieren
APA
Li, S., Bie, N., Wang, X., Huang, J., Zhang, X., Xu, S., Zhang, X., Liu, H., Xie, Z., Yong, T., Liu, Z., Yang, X., & Gan, L. (2025). Boosting Cancer Chemotherapy through Targeted Akkermansia muciniphila Modulation by Tumor-Repopulating Cell-Derived Microparticles. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c04399
Vancouver
Li S, Bie N, Wang X, Huang J, Zhang X, Xu S, et al. Boosting Cancer Chemotherapy through Targeted Akkermansia muciniphila Modulation by Tumor-Repopulating Cell-Derived Microparticles. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c04399
BibTeX
@article{Li2025,
author = {Li, Shiyu and Bie, Nana and Wang, Xiaojuan and Huang, Jinzhao and Zhang, Xiaoqiong and Xu, Shiyi and Zhang, Xiaojuan and Liu, Haojie and Xie, Zixiang and Yong, Tuying and Liu, Zhi and Yang, Xiangliang and Gan, Lu},
title = {Boosting Cancer Chemotherapy through Targeted Akkermansia muciniphila Modulation by Tumor-Repopulating Cell-Derived Microparticles},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.5c04399}
}
EUVIMED